ERX-41

Item no.	DCC-DC60261-100mg
Manufacturer	DCChemicals
CASRN	2440087-54-5
Amount	100 mg
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Applications	other
Specific against	other
Purity	>98%
Smiles	OCCOC1=C([N+]([O-])=O)C=CC(C(NC2=CC=C(C(NC3=CC=C(C(N[C@@H]4CC[C@@H](C)CC4)=O)C=C3OCC(C)C)=O)C=C2OCC(C)C)=O)=C1
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Manufacturer - Applications	ERX-41 is a potent therapeutic agent targeting lysosomal acid lipase A (LIPA) and shows the mechanism of action (disruption of protein folding and induction of ER stress) that may have utility in treating patients with TNBC or other multiple solid tumors.
Molecular Weight	704, 82

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 2/26/2026

Express Delivery: Save 2 days

Compare

Add to wishlist

Get an offer